evidence table

Ginkgo Attention Randomized Trial Evidence Table

Structured evidence table for Ginkgo Attention Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Ginkgo Attention Randomized TrialThe second study confirmed the GBP benefits on mood states and a visually consistent downward trend in reaction times across all four cognitive performance tests at both GBP dosages, suggesting improved processing speed in response to various stimuli.2Hawkins K (2026)Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
Ginkgo Attention Randomized TrialMental health is threatened every day by the stressors of life: frenetic work rhythms, stressful conditions can generate anxiety, depression, cognition, and sleep problems.2Hawkins K (2026)Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
Ginkgo Attention Randomized TrialAmong natural products with properties to support mental health, Gingko biloba extract with phosphatidylserine (GBP) was exploited with the aim of evaluating its benefits in cognitive function, mood regulation, and overall quality of life.2Hawkins K (2026)Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
Ginkgo Attention Randomized TrialIn addition, an overview of systematic reviews synthesized the broader EGb 761 evidence base across indications and highlighted that conclusions require caution given the methodological limitations of many reviews [].3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
Ginkgo Attention Randomized TrialReal-world observational analyses have also reported associations between prescriptions of Ginkgo leaf extract and reduced risk of dementia severity progression, albeit with the inherent limitations of non-randomized designs [].3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
Ginkgo Attention Randomized TrialAccordingly, this review revisits the historical evidence base with explicit attention to heterogeneity and methodological design, and then examines biomarker-confirmed AD-spectrum studies as a potential pivot point.3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
Ginkgo Attention Randomized Trial1 2 Alzheimer’s disease (AD) remains the most common cause of dementia and continues to impose a major burden on patients, caregivers, and healthcare systems [].3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Attention Randomized Trial
claimThe second study confirmed the GBP benefits on mood states and a visually consistent downward trend in reaction times across all four cognitive performance tests at both GBP dosages, suggesting improved processing speed in response to various stimuli.
evidence level2
citationHawkins K (2026)
sourceHealth Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
topicGinkgo Attention Randomized Trial
claimMental health is threatened every day by the stressors of life: frenetic work rhythms, stressful conditions can generate anxiety, depression, cognition, and sleep problems.
evidence level2
citationHawkins K (2026)
sourceHealth Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
topicGinkgo Attention Randomized Trial
claimAmong natural products with properties to support mental health, Gingko biloba extract with phosphatidylserine (GBP) was exploited with the aim of evaluating its benefits in cognitive function, mood regulation, and overall quality of life.
evidence level2
citationHawkins K (2026)
sourceHealth Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
topicGinkgo Attention Randomized Trial
claimIn addition, an overview of systematic reviews synthesized the broader EGb 761 evidence base across indications and highlighted that conclusions require caution given the methodological limitations of many reviews [].
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Attention Randomized Trial
claimReal-world observational analyses have also reported associations between prescriptions of Ginkgo leaf extract and reduced risk of dementia severity progression, albeit with the inherent limitations of non-randomized designs [].
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Attention Randomized Trial
claimAccordingly, this review revisits the historical evidence base with explicit attention to heterogeneity and methodological design, and then examines biomarker-confirmed AD-spectrum studies as a potential pivot point.
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Attention Randomized Trial
claim1 2 Alzheimer’s disease (AD) remains the most common cause of dementia and continues to impose a major burden on patients, caregivers, and healthcare systems [].
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?

Learn next

Related evidence and supplement guides

GuideGinkgo Attention Randomized Trial: What the Evidence SaysGinkgo Attention Randomized Trial has 2 source documents in the current Migaku evidence database...GuideGinkgo Biloba Memory Randomized Trial: What the Evidence SaysGinkgo Biloba Memory Randomized Trial has 2 source documents in the current Migaku evidence data...GuideSaffron Attention Randomized Trial: What the Evidence SaysSaffron Attention Randomized Trial has 2 source documents in the current Migaku evidence databas...GuideTheanine Attention Randomized Trial: What the Evidence SaysTheanine Attention Randomized Trial has 1 source documents in the current Migaku evidence databa...RankingBest Nootropics for Focus & Attention: 2026 Clinical Evidence ReviewWe separate the clinical evidence from the marketing hype, ranking the most effective brain supp...RankingBest Supplements for Anxiety: Evidence-Based Rankings 2026Anxiety supplements with genuine clinical evidence include ashwagandha (strongest for chronic an...RankingBest Collagen for Hair, Skin & Nails: 2026 Evidence-Based RankingsWe analyzed the amino acid concentrations and molecular weights of top collagen brands to identi...AnswerDoes Ginkgo Attention Randomized Trial work?Ginkgo Attention Randomized Trial has evidence relevant to strength of evidence and what the stu...

Source documents

  1. Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
  2. Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?